Experiments
Searchable full-text extractions: founding hypothesis, core claims, experimental setups, key results and statistics — pulled out of each paper as structure. Search a cell line, an assay or an entity (e.g. HUH7) and find every paper that worked with it. This corpus stands on its own: most entries carry no reproduction assessment (yet).
-
Full-text index only
Predicting the effect of CRISPR-Cas9-based epigenome editing.
PMID 41524535 · PMC12795505 · eLife · 2026 · 8 claims · 6 setups
Machine learning (CNN and ridge regression) models trained on histone PTM ChIP-seq and RNA-seq data from 13 ENCODE cell types accurately predict endogenous gene expression, with transcriptome-wide correlations of ~0.70-0.79 for most cell types
-
Full-text index only
Epigenetic and Transcriptional Programs Define Osteosarcoma Subtypes and Establish Targetable Vulnerabilities.
PMID 41037662 · PMC12877751 · Cancer discovery · 2026 · 8 claims · 7 setups
ATAC-seq profiling of osteosarcoma patient samples, PDXs, and PDX-CLs reveals two distinct chromatin accessibility subtypes: early osteoblast-derived (EOD) and late osteoblast-derived (LOD)
-
Full-text index only
EpiXFormer: a cross-attention neural network for predicting cell type-specific transcription factor binding sites.
PMID 41527854 · PMC12796812 · Briefings in bioinformatics · 2026 · 8 claims · 8 setups
EpiXFormer achieves high accuracy (mean AUROC ~0.99) predicting binding sites of both TFs and non-sequence-specific DBPs across 199 DBP-cell type pairs
-
Full-text index only
Evolutionary innovation within conserved gene regulatory networks underlying biomineralized skeletons in Bilateria.
PMID 41556888 · PMC12862220 · Molecular biology and evolution · 2026 · 8 claims · 6 setups
A biphasic regulatory program orchestrates larval and adult shell formation in Crassostrea nippona, involving coordinated activity of ancient transcription factors and dynamic chromatin remodeling
-
Has reproduction · 85
Epigenome screening highlights that JMJD6 confers an epigenetic vulnerability and mediates sunitinib sensitivity in renal cell carcinoma.
PMID 33634984 · PMC7882098 · Clinical and translational medicine · 2021 · 8 claims · 8 setups
JMJD6 is identified as a potent epigenetic vulnerability/fitness gene in RCC by integrating GeCK CRISPR screening data with TCGA-KIRC epigenetic regulator survival analysis
-
Full-text index only
SMARCA4/2 loss reduces BCL-xL expression and confers a druggable MCL1 dependency in cancer.
PMID 41807550 · PMC13249849 · NPJ precision oncology · 2026 · 8 claims · 8 setups
MCL1 inhibition is synthetic lethal with SMARCA4/2 loss in SCCOHT and NSCLC cells